Through multimodalities-based approaches, the current study observed that activation of FXR by chronic OCA treatment normalised cardiac Treg-represented (IL-10/IL10R) signals and attenuated the abovementioned pathogenic markers in NASH mouse hearts. This evidence concerns the gene IL10RA and metabolic dysfunction-associated steatohepatitis.